Lymphoproliferative Disorder
52
7
9
28
Key Insights
Highlights
Success Rate
76% trial completion
Published Results
13 trials with published results (25%)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 49/100
17.3%
9 terminated out of 52 trials
75.7%
-10.8% vs benchmark
17%
9 trials in Phase 3/4
46%
13 of 28 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 28 completed trials
Clinical Trials (52)
Nivolumab in Epstein-Barr Virus (EBV)-Positive Lymphoproliferative Disorders and EBV-Positive Non-HodgkinLymphomas
Project: Every Child for Younger Patients With Cancer
Virotherapy and Natural History Study of KHSV-Associated Multricentric Castleman s Disease With Correlates of Disease Activity
Busulfan, Fludarabine Phosphate, and Post-Transplant Cyclophosphamide in Treating Patients With Blood Cancer Undergoing Donor Stem Cell Transplant
Acalabrutinib and Obinutuzumab for the Treatment of Previously Untreated Follicular Lymphoma or Other Indolent Non-Hodgkin Lymphomas
Reduced Immunosuppressive Therapy With or Without Donor White Blood Cells in Treating Patients With Lymphoproliferative Disease After Organ Transplantation
Understanding the Mechanisms of Clonal and Non-clonal Cytopenia Following CAR-T Therapy for Multiple Myeloma or CD19+ Lymphoproliferative Disorder (LPD)
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer
Registry of Older Patients With Cancer
Treatment and Natural History Study of Lymphomatoid Granulomatosis
Collecting and Storing Tissue Samples From Patients With Rare or Cutaneous Non-Hodgkin Lymphoma
Vaccine Therapy For Patients Being Considered For Organ Transplant Who Are at Risk For PTLD
Collecting and Storing Blood Samples From Patients With Cancer
Pemetrexed Disodium in the Cerebrospinal Fluid of Patients With Leptomeningeal Metastases
Methadone, Morphine, or Oxycodone in Treating Pain in Patients With Cancer
Darbepoetin Alfa Compared With Epoetin Alfa in Treating Anemia in Patients Receiving Chemotherapy for Cancer
Bortezomib and Ganciclovir in Treating Patients With Relapsed or Refractory Epstein Barr Virus-Positive Lymphoma
Personalized Information or Basic Information in Helping Patients Make Decisions About Participating in a Clinical Trial
Most Closely HLA-Matched CTLs for Relapsed Epstein Barr Virus(EBV)-Associated Diseases